Cardinal Health buying Harvard Drug for $1.12B – USA TODAY


Bloomberg
Cardinal Health buying Harvard Drug for $1.12B
USA TODAY
Along with the boost to its generic business, Cardinal Health said the deal would expand its existing telesales programs and capability, broaden its portfolio of over-the-counter drugs and bring specialized packaging offerings designed to meet the
Cardinal Health to Buy Harvard Drug Group for $1.12 BillionBloomberg
Cardinal Health To Buy Generics Distributor Harvard Drug GroupWall Street Journal
Cardinal Health (CAH) to Acquire The Harvard Drug Group in $1.12B DealStreetInsider.com
PR Newswire (press release) -ABC News -Reuters
all 141 news articles >>

Source: health – Google News

Sharing information is key – Healthcare Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd